Analysts review Tango Therapeutics Inc’s rating

Tango Therapeutics Inc’s recent filing unveils that its 10% Owner Third Rock Ventures IV, L.P. unloaded Company’s shares for reported $4.01 million on Sep 25 ’25. In the deal valued at $8.02 per share,500,000 shares were sold. As a result of this transaction, Third Rock Ventures IV, L.P. now holds 13,863,975 shares worth roughly $101.07 million.

Then, Third Rock Ventures IV, L.P. bought 500,000 shares, generating $3,900,000 in total proceeds.

Before that, Third Rock Ventures IV, L.P. sold 363,541 shares. Tango Therapeutics Inc shares valued at $2,559,329 were divested by the 10% Owner at a price of $7.04 per share. As a result of the transaction, Third Rock Ventures IV, L.P. now holds 14,363,975 shares, worth roughly $104.71 million.

Piper Sandler initiated its Tango Therapeutics Inc [TNGX] rating to an Overweight in a research note published on August 19, 2025; the price target was $11. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in mid July with a ‘”a Buy”‘ rating. Cantor Fitzgerald began covering TNGX with “an Overweight” recommendation on April 04, 2024. Piper Sandler started covering the stock on February 12, 2024. It rated TNGX as “an Overweight”.

Price Performance Review of TNGX

On Tuesday, Tango Therapeutics Inc [NASDAQ:TNGX] saw its stock fall -3.83% to $7.29. Over the last five days, the stock has lost -13.21%. Tango Therapeutics Inc shares have risen nearly 5.65% since the year began. Nevertheless, the stocks have risen 135.92% over the past one year. While a 52-week high of $8.80 was reached on 09/29/25, a 52-week low of $1.03 was recorded on 05/08/25.

Levels Of Support And Resistance For TNGX Stock

The 24-hour chart illustrates a support level at 7.13, which if violated will result in even more drops to 6.96. On the upside, there is a resistance level at 7.59. A further resistance level may holdings at 7.89.

How much short interest is there in Tango Therapeutics Inc?

A steep rise in short interest was recorded in Tango Therapeutics Inc stocks on 2025-09-15, growing by 1.64 million shares to a total of 26.8 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-15 was 25.16 million shares. There was a rise of 6.13%, which implies that there is a positive sentiment for the stock.

The most recent change occurred on December 08, 2023 when B. Riley Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $16 price target.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.